What is the likelihood that Thoroughbred foals treated for septic arthritis will race?
Authors: Smith L J, Marr C M, Payne R J, Stoneham S J, Reid S W J
Journal: Equine veterinary journal
Summary
# Editorial Summary: Racing Outcomes After Neonatal Septic Arthritis in Thoroughbreds Septic arthritis remains a devastating diagnosis in neonatal foals, yet its long-term impact on racing careers has been poorly quantified until now. Smith and colleagues reviewed medical records of 69 Thoroughbred foals treated for septic arthritis, comparing their lifetime racing records against unaffected siblings from the same dams to provide robust prognostic data. Affected foals were significantly less likely to race (odds ratio 0.28), with those successfully discharged still showing substantially reduced racing prospects compared to controls (odds ratio 0.36). Moreover, foals that did go on to race started considerably later than their unaffected siblings—at a mean age of 1757 days versus 1273 days—suggesting lingering effects on training progression even after clinical recovery. These findings provide veterinarians and owners with evidence-based figures for realistic discussions about prognosis and athletic potential following septic arthritis, informing breeding and management decisions whilst emphasising the importance of early aggressive treatment to maximise the small proportion of foals that might eventually compete.
Read the full abstract on PubMed
Practical Takeaways
- •Owners and veterinarians should counsel that neonatal septic arthritis substantially reduces a foal's likelihood of ever starting on a racecourse, even with successful treatment and discharge
- •Recovery from septic arthritis significantly delays racing debut by approximately 1.3 years compared to unaffected foals, even among those that do eventually race
- •The presence of multisystem disease at presentation is the strongest predictor of not surviving to discharge, but should not discourage treatment in foals that do recover, as it does not further reduce racing prospects
Key Findings
- •Thoroughbred foals with septic arthritis were 72% less likely to race compared to unaffected siblings (OR 0.28, P=0.001)
- •Foals discharged after septic arthritis treatment remained 64% less likely to race than controls (OR 0.36, P=0.008)
- •Multisystem disease reduced likelihood of hospital discharge (OR 0.13, P=0.005) but did not affect racing likelihood if successfully discharged
- •Foals that recovered from septic arthritis started racing significantly later (mean 1757 days) compared to siblings (mean 1273 days, P=0.0006)